We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$611M
AUM Growth
+$61.5M
Cap. Flow
+$1.51M
Cap. Flow %
0.25%
Top 10 Hldgs %
8.42%
Holding
675
New
112
Increased
203
Reduced
170
Closed
94

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$3.54M
2
ALGN icon
Align Technology
ALGN
+$2.35M
3
HAL icon
Halliburton
HAL
+$2.04M
4
LYB icon
LyondellBasell Industries
LYB
+$2M
5
AVGO icon
Broadcom
AVGO
+$1.88M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.79M
2
KMI icon
Kinder Morgan
KMI
+$2.84M
3
DIS icon
Walt Disney
DIS
+$2.64M
4
VMW
VMware, Inc
VMW
+$2.56M
5
PFE icon
Pfizer
PFE
+$2.49M

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Financials 18.09%
3 Healthcare 13.8%
4 Industrials 13.04%
5 Consumer Discretionary 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
526
Annexon
ANNX
$883M
$212K 0.03%
46,698
– –
DFTX
527
Definium Therapeutics
DFTX
$5.99B
$208K 0.03%
56,957
– –
APD icon
528
Air Products & Chemicals
APD
$68.6B
$208K 0.03%
759
+19
+3% +$5.22K
VSTM icon
529
Verastem
VSTM
$615M
$206K 0.03%
25,274
– –
EDIT icon
530
Editas Medicine
EDIT
$432M
$203K 0.03%
+20,014
New +$176K
COGT icon
531
Cogent Biosciences
COGT
$7.1B
$202K 0.03%
+34,328
New +$263K
VYGR icon
532
Voyager Therapeutics
VYGR
$195M
$196K 0.03%
+23,217
New +$168K
ALEC icon
533
Alector
ALEC
$189M
$196K 0.03%
24,532
– –
ALLO icon
534
Allogene Therapeutics
ALLO
$725M
$195K 0.03%
+60,634
New +$172K
NRIX icon
535
Nurix Therapeutics
NRIX
$2.69B
$191K 0.03%
18,511
– –
MLYS icon
536
Mineralys Therapeutics
MLYS
$2.41B
$191K 0.03%
+22,209
New +$174K
CGEM icon
537
Cullinan Oncology
CGEM
$1.18B
$191K 0.03%
18,718
+127
+0.7% +$1.13K
LYEL icon
538
Lyell Immunopharma
LYEL
$351M
$188K 0.03%
4,856
– –
LONA
539
LeonaBio Inc
LONA
$70.5M
$183K 0.03%
7,539
– –
NUVB icon
540
Nuvation Bio
NUVB
$2.32B
$178K 0.03%
118,057
– –
LENZ
541
LENZ Therapeutics
LENZ
$168M
$172K 0.03%
9,362
– –
IPSC icon
542
Century Therapeutics
IPSC
$357M
$171K 0.03%
51,520
– –
FHTX icon
543
Foghorn Therapeutics
FHTX
$371M
$167K 0.03%
25,819
– –
GLUE icon
544
Monte Rosa Therapeutics
GLUE
$1.35B
$157K 0.03%
27,844
– –
GRTS
545
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$157K 0.03%
76,811
– –
FATE icon
546
Fate Therapeutics
FATE
$322M
$155K 0.03%
41,337
– –
STRO icon
547
Sutro Biopharma
STRO
$423M
$153K 0.03%
3,569
– –
CUE icon
548
Cue Biopharma
CUE
$110M
$153K 0.03%
1,930
– –
FHN icon
549
First Horizon
FHN
$12B
$151K 0.02%
10,662
– –
BCAB icon
550
BioAtla
BCAB
$5.76M
$151K 0.02%
1,224
– –
20 21
22
23 24

Similar funds

NWM
NRI Wealth Management Santa Clara, California $196M AUM 32.41% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund X Houston, Texas $216M AUM 11.92% 1-Year Est. Return
PSB
Passumpsic Savings Bank St. Johnsbury, Vermont $183M AUM
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
NMG
New Millennium Group Sandy, Utah $231M AUM 33.06% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
BC
Bowman & Company Oshkosh, Wisconsin $237M AUM 16.16% 1-Year Est. Return
EFA
Edge Financial Advisors Wheaton, Illinois $238M AUM 17.31% 1-Year Est. Return

Cornercap Investment Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Cornercap Investment Counsel held 675 positions worth $611M, up 11% from $550M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Cornercap Investment Counsel's Q4 2023 filing shows 112 new, 203 increased, 170 reduced and 94 closed positions. Its largest new stake was Align Technology: 9,904 shares worth $2.71M. The largest sale was ExxonMobil, an estimated $5.79M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Cornercap Investment Counsel's largest Q4 2023 buy was Align Technology: 9,904 shares worth $2.71M.
  • Cornercap Investment Counsel added most to Chevron in Q4 2023, an estimated $3.54M increase.
  • Cornercap Investment Counsel's biggest Q4 2023 reduction was ExxonMobil, cutting an estimated $5.79M.
  • Cornercap Investment Counsel fully exited VMware, Inc in Q4 2023, selling an estimated $2.56M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.4% of its $611M portfolio in Q4 2023.
  • Cornercap Investment Counsel opened 112 new positions and closed 94 in Q4 2023.
  • Cornercap Investment Counsel's portfolio value rose 11% quarter-over-quarter to $611M.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.